{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:47:30Z","timestamp":1778273250429,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["IFRR 115349"],"award-info":[{"award-number":["IFRR 115349"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IR173"],"award-info":[{"award-number":["IR173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MHOM\/IN\/95\/9515"],"award-info":[{"award-number":["MHOM\/IN\/95\/9515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MHOM\/IR\/-173"],"award-info":[{"award-number":["MHOM\/IR\/-173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MHOM\/SD\/62\/1S"],"award-info":[{"award-number":["MHOM\/SD\/62\/1S"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-48816"],"award-info":[{"award-number":["NR-48816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-48821"],"award-info":[{"award-number":["NR-48821"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-48822"],"award-info":[{"award-number":["NR-48822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.exppara.2022.108249","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:37:35Z","timestamp":1647689855000},"page":"108249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["In vitro antileishmanial efficacy of antiplasmodial active aminoquinoline-chalcone hybrids"],"prefix":"10.1016","volume":"236-237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3685-5532","authenticated-orcid":false,"given":"Janine","family":"Aucamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-0551","authenticated-orcid":false,"given":"David D.","family":"N\u2019Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2022.108249_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171102","article-title":"Optimal control and cost-effective analysis of malaria\/visceral leishmaniasis co-infection","volume":"12","author":"Agusto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2022.108249_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exppara.2016.10.009","article-title":"Aminoquinoline compounds: effect of 7-chloro-4-quinolinylhydrazone derivatives against","volume":"171","author":"Antinarelli","year":"2016","journal-title":"Leishmania amazonensis. Exp Parasitol"},{"key":"10.1016\/j.exppara.2022.108249_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exppara.2018.10.007","article-title":"Antileishmanial activity of a 4-hydrazinoquinoline derivative: induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis","volume":"195","author":"Antinarelli","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2022.108249_bib4","series-title":"Basic and Clinical Pharmacology","first-page":"826","article-title":"Aminoglycosides and spectinomycin","author":"Beauduy","year":"2018"},{"issue":"10","key":"10.1016\/j.exppara.2022.108249_bib5","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-03-1084","article-title":"Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs","volume":"104","author":"Biagini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exppara.2022.108249_bib6","author":"CDC Centers for disease control and prevention"},{"key":"10.1016\/j.exppara.2022.108249_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bioorg.2018.10.053","article-title":"Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents","volume":"83","author":"Chanquia","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.exppara.2022.108249_bib8","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.45.7.2023-2029.2001","article-title":"Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones","volume":"45","author":"Chen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108249_bib9","doi-asserted-by":"crossref","first-page":"1900350","DOI":"10.1002\/ardp.201900350","article-title":"Chalcone hybrids and their antimalarial activity","volume":"353","author":"Cheng","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.exppara.2022.108249_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2016.10.017","article-title":"Quinoline derivatives: synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action","volume":"25","author":"Coimbra","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"3 Suppl. l","key":"10.1016\/j.exppara.2022.108249_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2022.108249_bib12","first-page":"1780","article-title":"Experimental and computational evaluation of new quinolinyl chalcones as potent antiplasmodial agents","volume":"48B","author":"Dave","year":"2009","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.exppara.2022.108249_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2018.03.047","article-title":"A comprehensive review of chalcone derivatives as antileishmanial agents","volume":"150","author":"de Mello","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.exppara.2022.108249_bib14","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2022.108249_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40249-020-0630-9","article-title":"Neglected tropical diseases: an effective global response to local poverty-related disease priorities","volume":"9","author":"Engels","year":"2020","journal-title":"Infect dis poverty"},{"key":"10.1016\/j.exppara.2022.108249_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00044-017-2076-6","article-title":"Synthesis and antiprotozoal activity of furanchalcone-quinoline, furanchalcone-chomone and furanchalcone-imidazole hybrids","volume":"27","author":"Garcia","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.exppara.2022.108249_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157340607780059530","article-title":"Antileishmanial and antimalarial chalcones: synthesis, efficacy and cytotoxicity of pyridinyl and naphthalenyl analogs","volume":"3","author":"Gutteridge","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.exppara.2022.108249_bib18","article-title":"A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP-1 human acute monocytic leukemia cell line","volume":"70","author":"Jain","year":"2012","journal-title":"JoVE"},{"key":"10.1016\/j.exppara.2022.108249_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exppara.2022.108249_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000280","article-title":"Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives","volume":"354","author":"Mangwegape","year":"2021","journal-title":"Arch Pharm"},{"issue":"3","key":"10.1016\/j.exppara.2022.108249_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006125","article-title":"Tegumentary leishmaniasis and coinfections other than HIV","volume":"12","author":"Mart\u00ednez","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"3","key":"10.1016\/j.exppara.2022.108249_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.40.3.586","article-title":"Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis","volume":"40","author":"Murray","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108249_bib23","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/AAC.00645-07","article-title":"Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate","volume":"52","author":"Nanayakkara","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108249_bib24","article-title":"Screening of anti-infectives against","volume":"6","author":"Nettey","year":"2016","journal-title":"Leishmania donovani. Adv Microbiol"},{"key":"10.1016\/j.exppara.2022.108249_bib25","first-page":"115","article-title":"Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review","volume":"42","author":"Parhizgar","year":"2017","journal-title":"Iran. J. Med. Sci."},{"issue":"16","key":"10.1016\/j.exppara.2022.108249_bib26","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1073\/pnas.0307742101","article-title":"A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation","volume":"101","author":"Pessi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.exppara.2022.108249_bib27","first-page":"982","article-title":"Malaria-cutaneous leishmaniasis co-infection: influence on disease outcomes and immune response","volume":"7","author":"Pinna","year":"2016","journal-title":"Front Micriobiol"},{"issue":"10","key":"10.1016\/j.exppara.2022.108249_bib28","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite","volume":"72","author":"Potvin","year":"2021","journal-title":"Leishmania donovani. Clin infect dis"},{"key":"10.1016\/j.exppara.2022.108249_bib29","doi-asserted-by":"crossref","first-page":"112215","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108249_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","article-title":"Chalcone synthesis, properties and medicinal applications: a review","volume":"18","author":"Rammohan","year":"2020","journal-title":"Environ. Chem. Lett."},{"issue":"7","key":"10.1016\/j.exppara.2022.108249_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jmm.0.058115-0","article-title":"Activity of antimalarial drugs in vitro and in a murine model of cutaneous leishmaniasis","volume":"62","author":"Rocha","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.exppara.2022.108249_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"Sen","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2022.108249_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2010.00990.x","article-title":"Invasion and intracellular survival by protozoan parasites","volume":"240","author":"Sibley","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exppara.2022.108249_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijid.2015.11.006","article-title":"Impacts of neglected tropical disease on incidence and progression of HIV\/AIDS, tuberculosis, and malaria: scientific links","volume":"42","author":"Simon","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.exppara.2022.108249_bib35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bmc.2013.12.032","article-title":"Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides","volume":"22","author":"Smit","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108249_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2014.11.016","article-title":"Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters","volume":"90","author":"Smit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.exppara.2022.108249_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.exppara.2022.108249_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpddr.2017.03.004","article-title":"Using a genome-scale metabolic network model to elucidate the mechanism of chloroquine action in","volume":"7","author":"Tewari","year":"2017","journal-title":"Plasmodium falciparum. Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.exppara.2022.108249_bib39","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/acs.jmedchem.9b00628","article-title":"Synthesis, biological evaluation, structure\u2013activity relationship, and mechanism of action studies of quinoline\u2013metronidazole derivatives against experimental visceral leishmaniasis","volume":"62","author":"Upadhyay","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108249_bib40","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2022.108249_bib41","first-page":"1","volume":"vol. 949","author":"WHO Expert Committee on the Control of the Leishmaniases & WHO","year":"2010"},{"key":"10.1016\/j.exppara.2022.108249_bib42","author":"WHO"},{"key":"10.1016\/j.exppara.2022.108249_bib43","author":"WHO"},{"key":"10.1016\/j.exppara.2022.108249_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12936-017-1725-z","article-title":"Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria","volume":"16","author":"Yeo","year":"2017","journal-title":"Malar. J."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:03:32Z","timestamp":1762149812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489422000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":44,"alternative-id":["S0014489422000431"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108249","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antileishmanial efficacy of antiplasmodial active aminoquinoline-chalcone hybrids","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108249"}}